Lila Kagit Sanayi Ve Ticaret Anonim Sirketi

Lila Kagit Sanayi Ve Ticaret Anonim Sirketi

BBIST:LILAK
20.26
TRY
-0.62
(-2.97%)
21.71BMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11.05
21.36
22.89
29.31
23.06
- -
Basic EPS, GAAP
1.26
3.48
0.55
2.75
2.89
- -
Free Cash Flow per Basic Share
3.19
2.57
6.77
7.18
3.42
4.89
Dividend per Share
- -
- -
0.39
0.47
1.79
0.08
Book Value per Share
5.27
8.51
12.45
26.38
27.5
31.38
Tangible Book Value per Share
5.24
8.48
12.4
26.31
27.4
31.27
Basic Weighted Avg Shares
590
590
590
559
590
590
Sales/Revenue/Turnover
6,517
12,605
13,507
16,385
13,604
- -
Operating Margin (%)
20.63
22.05
17.37
13.75
13.42
- -
Depreciation Expense
40
53
666
954
818
829
Net Income, GAAP
746
2,053
324
1,538
1,704
- -
Effective Tax Rate (%)
- -
7.26
45.04
22.22
- -
- -
Profit Margin (%)
11.44
16.29
2.4
9.39
12.53
- -
Working Capital
890
2,015
2,615
9,283
9,091
9,717
LT Debt
1,786
890
841
769
831
1,554
Total Equity
3,107
5,018
7,345
15,563
16,226
18,516
Return on Invested Capital (%)
- -
33.31
14.34
13.62
- -
- -
Return on Capital (%)
- -
27.84
5.29
12.35
- -
- -
Return on Common Equity (%)
- -
50.54
5.24
13.43
10.72
- -

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
892
376
561
LT Borrowings
798
813
1,525
LT Finance Leases
33
31
29
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
590
590
590
Market Capitalization
17,110
22,137
21,712

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
10,950
11,427
14,294
Cash, Cash Equivalents & STI
5,932
5,870
7,556
Accounts Receivable, Net
2,996
3,382
3,791
Inventories
1,642
1,655
2,241
Total Current Liabilities
1,858
3,143
4,576
Payables & Accruals
- -
- -
- -
ST Debt
892
376
561
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
4.26%
Free Cash Flow
- -
- -
-49.66%
Net Income, GAAP
- -
- -
10.76%
Sales/Revenue/Turnover
- -
- -
-16.98%
Total Cash Common Dividend
- -
- -
298.84%

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,590
3,923
4,029
3,262
16,385
2025
3,945
4,271
- -
3,505
13,604
2026
3,190
3,858
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.28
1.02
0.79
0.33
2.75
2025
- -
2.09
- -
0.5
2.89
2026
-0.24
0.82
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.02
0.47
2025
- -
- -
- -
0.08
1.79
2026
- -
- -
- -
- -
- -

Company Description

CEO
Alp Ögücü
Full Time Employees
994
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Business Istanbul Merdivenköy Mahallesi Kadikoy IB Turkey 34732
IPO Date
May 9, 2024
Business
Lila Kagit Sanayi ve Ticaret AS (LILAK.IS) manufactures and sells hygienic tissue paper products and roll papers primarily in Turkey with exports to over 80 countries across five continents. The company produces a wide range of consumer and professional hygiene products including toilet paper, paper towels, napkins, facial tissues, handkerchiefs, pocket tissues, examination tablecloths and dispenser products under its own brands Sofia, Maylo, Ultra Berrak, Nua and Nua Professional as well as private label offerings; it also supplies semi-finished jumbo rolls as raw materials to converting facilities worldwide from its production facility with an annual capacity of 271,000 tons. Founded in 2006 and headquartered in Istanbul, Turkey, Lila Kagit operates through subsidiaries including Lila Tekstil for integrated cotton yarn production and dyeing services and maintains a fossil fuel power plant to supply energy for its facilities. The company serves both fast-moving consumer goods and away-from-home professional markets with a focus on sustainability using certified cellulose from industrial forests. In recent developments, Lila Kagit completed its fourth tissue production line (TM4) in 2022 increasing total paper capacity to 271,000 tons per year and reached converting capacity of 120,000 tons per year by 2023; it initiated construction of a new 35,000-ton hygienic tissue paper facility in Erzurum, eastern Turkey in 2023 boosting overall capacity toward 306,000 tons, commenced a public offering, and reported 15% sales growth to 160,000 tons in the first nine months of 2024 amid ongoing investments for sustainable expansion.